Leith Wheeler Investment Counsel Ltd. Astrazeneca PLC Transaction History

Leith Wheeler Investment Counsel Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$64.85 - $71.7 $2.71 Million - $3 Million	41,828 Added 51.76%	122,638 $8.31 Million
Q2 2023 Jul 18, 2023	BUY	$69.91 - $75.81 $464,901 - $504,136	6,650 Added 8.97%	80,810 $5.78 Million
Q1 2023 May 10, 2023	BUY	$63.15 - $71.6 $299,962 - $340,100	4,750 Added 6.84%	74,160 $5.15 Million
Q4 2022 Jan 11, 2023	BUY	$54.21 - $70.44 $352,365 - $457,860	6,500 Added 10.33%	69,410 $4.71 Million
Q3 2022 Oct 12, 2022	BUY	$53.02 - $135.75 $1.3 Million - $3.33 Million	24,550 Added 64.0%	62,910 $3.45 Million
Q2 2022 Jul 14, 2022	BUY	$59.26 - $71.14 $920,070 - $1.1 Million	15,526 Added 68.0%	38,360 $3.26 Million
Q1 2022 Apr 20, 2022	BUY	$55.72 - $67.12 $1.27 Million - $1.53 Million	22,834 New	22,834 $1.52 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Leith Wheeler Investment Counsel Ltd., based on Form 13F filings with the SEC.

Stay updated on Leith Wheeler Investment Counsel Ltd. with notifications on news.